| Filed On | Filing |
|---|---|
| 08 Mar 2024 |
8-K/A: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +5 more
On March 4, 2024, Avinger, Inc. (“Avinger” or the “Company”) entered into a License and Distribution Agreement (the “License Agreement”) with Zylox-Tonbridge Medical Technology Co., Ltd. (“Zylox-Tonbridge”) effective as of the Initial Cl... |
| 01 Dec 2023 |
8-K/A: Other Events
On November 28, 2023, Avinger, Inc. (the “Company”) requested and was granted a hearing before the Nasdaq Hearings Panel (the “Panel”), which hearing has been scheduled for March 14, 2024. The Company’s request for a hearing stayed any f... |
| 12 Sep 2023 |
8-K/A: Material Modification to Rights of Security Holders; Amendments to Articles/Bylaws; Change in Fiscal Year
Avinger, Inc., a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the “Corporation”), hereby certifies as follows: |
| 23 Dec 2020 | 8-K/A: Submission of Matters to a Vote of Security Holders |
| 15 May 2018 | 8-K/A: Results of Operations and Financial Condition |
| 15 Mar 2017 | 8-K/A: Results of Operations and Financial Condition |
Loading...
